Filtered By:
Vaccination: Cancer Vaccines
This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 733 results found since Jan 2013.
5 Things Healthcare Lost In 2021
As 2020 passed, we all thought we’d be better off with 2021, so we were happy to roll the old year off the cliff (or blow it off, for that matter). When setting expectations for the new norm, masks, some social distancing and even a subtle range of vaccines lined up were being considered… But not this. Nearing the end of 2021, we think of the end of the pandemic as a white sail gleams in the distance (and just as we publish this article, news arose of yet another virus mutant called omicron).
In 2021, we could’ve gotten over with the pandemic, period. But, (as it was famously said in the movie Charlie Wilsonâ€...
Source: The Medical Futurist - November 30, 2021 Category: Information Technology Authors: Judit Kuszkó Tags: Covid-19 Digital Health Research Future of Medicine Healthcare Design Healthcare Policy Medical Education cancer ptsd burnout cultural transformation Patreon conspiracy Source Type: blogs
Digital Health Interests Of Pharma Giants Boehringer Ingelheim, Takeda, Astrazeneca, Amgen And Roche
With their extending reaches, resources and influence, pharmaceutical heavyweights have the potential to shape the digital health landscape to line up with their interests. And to have a better picture of where those interests lie, it is worth taking a look at what moves pharma giants are making in this sphere. With this in mind, we started a series of articles focusing on the digital health efforts of 14 global pharma companies.
The first article explored developments coming from Johnson & Johnson, Pfizer, Bayer and Novartis, while the second article investigated those coming from Merck, GlaxoSmithKline, AbbV...
Source: The Medical Futurist - November 4, 2021 Category: Information Technology Authors: Pranavsingh Dhunnoo Tags: TMF Artificial Intelligence in Medicine Digital Health Research Future of Pharma sleep patient empowerment pharmaceutics roche MySugr Astra-Zeneca DTx takeda Boehringer Ingelheim Amgen digitisation Quire.ai Renalytix Eko Source Type: blogs
Reflections on HLTH2021: The Lens of the Patient and Carepartner
By GRACE CORDOVANO
Attending HLTH 2021 in-person in Boston solidified that there is no comparison between attending live vs. virtual conferences. While content and presentations can be solid both virtually or in-person, it is the energy of the connections that are made between scheduled presentations and the conversations that are shared throughout that move the needle. Kudos to the organizers of HLTH 2021 for prioritizing the safety of all in-person attendees with COVID-19 vaccination requirements, proof of negative PCR testing within 3 days of arrival, and mask requirements on-site.
After reflecting on all th...
Source: The Health Care Blog - November 3, 2021 Category: Consumer Health News Authors: Christina Liu Tags: Health Tech Grace Cordovano HLTH Patient advocates patient centered innovation Source Type: blogs
Years lost: boosting life expectancy through preventative health interventions
This report finds: over the past decades, life expectancy has significantly improved across the G20; across the G20, there has been a shift from cardiovascular disease as the leading cause of death to cancer, which overtook cardiovascular conditions in 2016 due to improvements in prevention, detection and treatment; and neurological conditions, including dementia, are now the leading cause of death in richer countries, including the US, UK and Saudi Arabia. However, the report also warns that while overall improvements in life expectancy are promising, too many years are still lost due to preventable causes. The ILC is cal...
Source: Health Management Specialist Library - November 2, 2021 Category: UK Health Authors: The King ' s Fund Library Tags: Public health and health inequalities Source Type: blogs
Merck, GlaxoSmithKline, AbbVie, Sanofi & Bristol Myers Squibb: Big Pharma ’s Extending Digital Health Reaches
A few weeks ago, we kickstarted a new series of articles contemplating the moves of pharmaceutical heavyweights in the digital health arena. The first batch of companies, Johnson & Johnson, Pfizer, Bayer and Novartis, seem to have some interest in remote healthcare solutions and DTx.
In this second article, we will explore which trends pharma giants Merck, GlaxoSmithKline, AbbVie, Sanofi and Bristol Myers Squibb are eyeing.
Merck: big tech-friendly
A big pharma company itself, Germany’s Merck hasn’t shied from teaming up with big tech companies in recent years as it aims to make a lasting footpri...
Source: The Medical Futurist - October 26, 2021 Category: Information Technology Authors: Pranavsingh Dhunnoo Tags: Artificial Intelligence in Medicine Biotechnology Future of Medicine Future of Pharma Health Sensors & Trackers Personalized Medicine Portable Medical Diagnostics Security & Privacy pharmaceutics 23andme philips big pharma Merck Source Type: blogs
Fight Aging! Newsletter, October 25th 2021
This study confirmed that the PSI could be a quantitative index of vascular aging and has potential for use in inferring arterial stiffness with an advantage over the rAIx.
A Profile of Michael Greve and the Segment of the Longevity Industry that He Supports
https://www.fightaging.org/archives/2021/10/a-profile-of-michael-greve-and-the-segment-of-the-longevity-industry-that-he-supports/
Would that the popular media produced more popular science articles about the longevity industry like this one. It is not just a profile of someone trying to make a difference in the world by advancing the state of medici...
Source: Fight Aging! - October 24, 2021 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Fight Aging! Newsletter, October 4th 2021
In conclusion, premature thymic involution and chronic inflammation greatly contribute to increased morbidity and mortality in CKD patients. Mechanisms are likely to be multiple and interlinked. Even when the quest to fountain of youth is a pipe dream, there are many scientific opportunities to prevent or to, at least in part, reverse CKD-related immune senescence. Further studies should precisely define most important pathways driving premature immune ageing in CKD patients and best therapeutic options to control them.
Extending Life Without Extending Health: Vast Effort Directed to the Wrong Goals
https://www...
Source: Fight Aging! - October 3, 2021 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
I ’m grateful for your trust in me. I wish it didn’t require a cancer diagnosis to win it.
You are my favorite patient. You’re charming and funny. You proudly tell me you’ve just retired – having built multiple successful businesses from scratch. You were admitted to my service with rapidly progressive respiratory failure. Your CT shows cancer everywhere. You are the same age as my husband.“I’m not getting that vaccine. It’s myRead more …I’m grateful for your trust in me. I wish it didn’t require a cancer diagnosis to win it. originally appeared inKevinMD.com.
Source: Kevin, M.D. - Medical Weblog - October 2, 2021 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/blog/post-author/cynthia-cooper" rel="tag" > Cynthia Cooper, MD < /a > < /span > Tags: Physician COVID-19 coronavirus Hospital-Based Medicine Infectious Disease Oncology/Hematology Source Type: blogs
Chronic Kidney Disease and an Accelerated Aging of the Immune System
In conclusion, premature thymic involution and chronic inflammation greatly contribute to increased morbidity and mortality in CKD patients. Mechanisms are likely to be multiple and interlinked. Even when the quest to fountain of youth is a pipe dream, there are many scientific opportunities to prevent or to, at least in part, reverse CKD-related immune senescence. Further studies should precisely define most important pathways driving premature immune ageing in CKD patients and best therapeutic options to control them.
Source: Fight Aging! - September 29, 2021 Category: Research Authors: Reason Tags: Medicine, Biotech, Research Source Type: blogs
Towards Better Cancer Vaccines via Identification of Important Neoantigens and T Cell Populations
Tumor cells have identifying surface markers that the immune system can in principle attack, but vaccination against those surface markers in order to encourage an anti-tumor immune response has been hit and miss. Researchers here dig deeper into the mechanisms that may explain this variability in response, and thus allow a more viable approach to patient-specific cancer vaccines that will more effectively rouse the immune system to target cancerous cells.
When cells begin to turn cancerous, they start producing mutated proteins not seen in healthy cells. These cancerous proteins, also called neoantigens, can aler...
Source: Fight Aging! - September 28, 2021 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
An urgent message
I get a lot of strange e-mails, but every once in a while something comes across Your Intertubes that is essential reading. This cannot be ignored.experts and scholars: The content in the attachment is provided to you by the dean of the World Academy of Sciences, superpowered scientists, the final review member of the Prophet International Union Cult Appraisal Committee ，The double-edged sword in Revelation Bible prophecy --- King Kong Prophet Su Bei Jian, and the Prophet International Union Including " The main reason for global abnormal natural disasters " , " Floods caused by rapid de...
Source: Stayin' Alive - September 10, 2021 Category: American Health Source Type: blogs
Cancer
I sometimes like to open my posts with a joke. But not this time. There isn ' t a joke for this.Mrs. Dalai has cancer.How ' s that for a kick in the ass? I am neither vain nor arrogant enough to think that I could write the ultimate treatise on dealing with a loved one ' s cancer. There are any number of engaging stories out there on Caring Bridge and the like. You don ' t want to read a tear-jerker anyway, nor do you want to endure every last boring and/or gory detail. Mrs. Dalai would be very upset with me if I shared all that. Hell, she ' s probably going to be upset with me for writing this at all. She is a very p...
Source: Dalai's PACS Blog - September 4, 2021 Category: Radiology Source Type: blogs
Fight Aging! Newsletter, August 30th 2021
Fight Aging! publishes news and commentary relevant to the goal of ending all age-related disease, to be achieved by bringing the mechanisms of aging under the control of modern medicine. This weekly newsletter is sent to thousands of interested subscribers. To subscribe or unsubscribe from the newsletter, please visit:
https://www.fightaging.org/newsletter/
Longevity Industry Consulting Services
Reason, the founder of Fight Aging! and Repair Biotechnologies, offers strategic consulting services to investors, entrepreneurs, and others interested in the longevity industry and its complexities. To find out mo...
Source: Fight Aging! - August 29, 2021 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
George Halvorson HIMSS Changemaker Lifetime Achievement Award Acceptance Speech, Part 2
Former Kaiser Permanente CEO George Halvorson has written on THCB on and off over the years, most notably last year with his proposal for Medicare Advantage for All post-COVID. This month he was given a lifetime achievement award by HIMSS and we are running his acceptance speech in two parts. We ran part one last week, and here’s part two– Matthew Holt
We also initially have an important and continuously improving sense of the epigenetic processes that exist in all of us to develop our own responses to the world we are in at a biological level, and we should be able to use that information to improve ou...
Source: The Health Care Blog - August 23, 2021 Category: Consumer Health News Authors: matthew holt Tags: Health Tech Health Technology Early Childhood Education George Halvorson HIMSS Changemaker Lifetime Achievement Award payment models Source Type: blogs
Fight Aging! Newsletter, August 23rd 2021
In this study, we used the UK Biobank (n = 440,185) to resolve previous ambiguities in the relationship between serum IGF-1 levels and clinical disease. We examined prospective associations of serum IGF-1 with mortality, dementia, vascular disease, diabetes, osteoporosis, and cancer, finding two generalized patterns.
First, IGF-1 interacts with age to modify risk in a manner consistent with antagonistic pleiotropy; younger individuals with high IGF-1 are protected from disease, while older individuals with high IGF-1 are at increased risk for incident disease or death. Second, the association between IGF-1 and risk ...
Source: Fight Aging! - August 22, 2021 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
